Prosthetic joint infection: Recent developments in diagnosis and management

Journal of Infection

Volumn 61, Issue 6, 2010, Pages 443-448

  Cataldo, Maria Adriana ^a   Petrosillo, Nicola ^a   Cipriani, Michela ^b   Cauda, Roberto ^b   Tacconelli, Evelina ^b  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Diagnosis; Prosthetic joint infection; Therapy

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; DAPTOMYCIN; LINEZOLID; MINOCYCLINE; NAFCILLIN; OXACILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; AREA UNDER THE CURVE; BONE INFECTION; CANDIDA; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DEBRIDEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG ABSORPTION; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG TISSUE LEVEL; ENTEROBACTERIACEAE INFECTION; ERADICATION THERAPY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEALTH CARE COST; HUMAN; INCIDENCE; INFECTIOUS ARTHRITIS; JOINT FUNCTION; JOINT PROSTHESIS; JOINT RADIOGRAPHY; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; PROSTHESIS INFECTION; RECURRENCE RISK; REOPERATION; REVIEW; RISK REDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS; SURGICAL INFECTION;

ARTHRITIS; ARTHROPLASTY, REPLACEMENT; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; HUMANS; INCIDENCE; PROSTHESIS-RELATED INFECTIONS;

EID: 78649630340     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.09.033     Document Type: Review

References (64)

1. National Hospital Discharge Survey Survey results and products 2009, Available at, Center for Disease Control and Prevention, Atlanta, [last access 14.09.10]. http://www.cdc.gov/nchs/nhds_products.html.
2. UK National Joint Registry Available at. http://www.njrcentre.org.uk.
3. Kurtz S., Ong K., Lau E., Mowat F., Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007, 89(4):780-785.
4. Lentino J.R. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis 2003, 36(9):1157-1161.
5. Zimmerli W. Infection and musculoskeletal conditions: prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol 2006, 20(6):1045-1063. 10.1016/j.berh.2006.08.003.
6. Sculco T.P. The economic impact of infected joint arthroplasty. Orthopedics 1995, 18(9):871-873.
7. Berbari E.F., Hanssen A.D., Duffy M.C., Steckelberg J.M., Ilstrup D.M., Harmsen W.S., et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998, 27(5):1247-1254.
8. Trampuz A., Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly 2005, 135(17-18):243-251.
9. Müller M., Morawietz L., Hasart O., Strube P., Perka C., Tohtz S. Diagnosis of periprosthetic infection following total hip arthroplasty-evaluation of the diagnostic values of pre- and intraoperative parameters and the associated strategy to preoperatively select patients with a high probability of joint infection. J Orthop Surg Res 2008, 3:31.
10. Zimmerli W., Trampuz A., Ochsner P.E. Prosthetic-joint infections. N Engl J Med 2004, 351(16):1645-1654.
11. Trampuz A., Widmer A.F. Infections associated with orthopedic implants. Curr Opin Infect Dis 2006, 19(4):349-356.
12. Hoekman P., Van de Perre P., Nelissen J., Kwisanga B., Bogaerts J., Kanyangabo F. Increased frequency of infection after open reduction of fractures in patients who are seropositive for human immunodeficiency virus. J Bone Joint Surg Am 1991, 73(5):675-679.
13. Garibaldi R.A., Cushing D., Lerer T. Risk factors for postoperative infection. Am J Med 1991, 91(3B):158S-163S.
14. Hanssen A.D., Rand J.A. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect 1999, 48:111-122.
15. Ilstrup D.M., Nolan D.R., Beckenbaugh R.D., Coventry M.B. Factors influencing the results in 2,012 total hip arthroplasties. Clin Orthop Relat Res 1973, 95:250-262.
16. Kendall R.W., Duncan C.P., Smith J.A., Ngui-Yen J.H. Persistence of bacteria on antibiotic loaded acrylic depots. A reason for caution. Clin Orthop Relat Res 1996, 329:273-280.
17. Uçkay I., Lübbeke A., Emonet S., Tovmirzaeva L., Stern R., Ferry T., et al. Low incidence of haematogenous seeding to total hip and knee prostheses in patients with remote infections. J Infect 2009 Nov, 59(5):337-345. 10.1016/j.jinf.2009.08.015.
18. Moran E., Masters S., Berendt A.R., McLardy-Smith P., Byren I., Atkins B.L. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 2007, 55(1):1-7. 10.1016/j.jinf.2007.01.007.
19. Hsieh P.H., Lee M.S., Hsu K.Y., Chang Y.H., Shih H.N., Ueng S.W. Gram-negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis 2009, 49(7):1036-1043.
20. Legout L., Senneville E., Stern R., Yazdanpanah Y., Savage C., Roussel-Delvalez M., et al. Treatment of bone and joint infections caused by gram-negative bacilli with a cefepime-fluoroquinolone combination. Clin Microbiol Infect 2006, 12(10):1030-1033.
21. Sia I.G., Berbari E.F., Karchmer A.W. Prosthetic joint infections. Infect Dis Clin North Am 2005, 19(4):885-914. 10.1016/j.idc.2005.07.010.
22. Berbari E.F., Marculescu C., Sia I., Lahr B.D., Hanssen A.D., Steckelberg J.M., et al. Culture-negative prosthetic joint infection. Clin Infect Dis 2007 Nov 1, 45(9):1113-1119.
23. Marculescu C.E., Berbari E.F., Cockerill F.R., Osmon D.R. Fungi, mycobacteria, zoonotic and other organisms in prosthetic joint infection. Clin Orthop Relat Res 2006, 451:64-72.
24. Salgado C.D., Dash S., Cantey J.R., Marculescu C.E. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 2007, 461:48-53.
25. Bilgen O., Atici T., Durak K., Karaeminoĝullari O., Bilgen M.S. C-reactive protein values and erythrocyte sedimentation rates after total hip and total knee arthroplasty. J Int Med Res 2001, 29(1):7-12.
26. Bottner F., Wegner A., Winkelmann W., Becker K., Erren M., Götze C. Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br 2007, 89(1):94-99.
27. Pavoni G.L., Giannella M., Falcone M., Scorzolini L., Liberatore M., Carlesimo B., et al. Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience. Clin Microbiol Infect 2004, 10:831-837.
28. Vandercam B., Jeumont S., Cornu O., Yombi J.C., Lecouvet F., Lefèvre P., et al. Amplification-based DNA analysis in the diagnosis of prosthetic joint infection. J Mol Diagn 2008, 10(6):537-543.
29. Gallo J., Kolar M., Dendis M., Loveckova Y., Sauer P., Zapletalova J., et al. Culture and PCR analysis of joint fluid in the diagnosis of prosthetic joint infection. New Microbiol 2008, 31(1):97-104.
30. Panousis K., Grigoris P., Butcher I., Rana B., Reilly J.H., Hamblen D.L. Poor predictive value of broad-range PCR for the detection of arthroplasty infection in 92 cases. Acta Orthop 2005, 76(3):341-346.
31. De Man F.H., Graber P., Lüem M., Zimmerli W., Ochsner P.E., Sendi P. Broad-range PCR in selected episodes of prosthetic joint infection. Infection 2009, 37(3):292-294.
32. Fihman V., Hannouche D., Bousson V., Bardin T., Lioté F., Raskine L., et al. Improved diagnosis specificity in bone and joint infections using molecular techniques. J Infect 2007, 55:510-517. 10.1016/j.jinf.2007.09.001.
33. Dora C., Altwegg M., Gerber C., Böttger E.C., Zbinden R. Evaluation of conventional microbiological procedures and molecular genetic techniques for diagnosis of infections in patients with implanted orthopedic devices. J Clin Microbiol 2008, 46(2):824-825.
34. Parvizi J., Ghanem E., Sharkey P., Aggarwal A., Burnett R.S., Barrack R.L. Diagnosis of infected total knee: findings of a multicenter database. Clin Orthop Relat Res 2008, 466(11):2628-2633.
35. Trampuz A., Piper K.E., Jacobson M.J., Hanssen A.D., Unni K.K., Osmon D.R., et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007, 357(7):654-663.
36. Sendi P., Frei R., Maurer T.B., Trampuz A., Zimmerli W., Graber P. Escherichia coli variants in periprosthetic joint infection: diagnostic challenges with sessile bacteria and sonication. J Clin Microbiol 2010, 48(5):1720-1725.
37. Smith S.L., Wastie M.L., Forster I. Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement. Clin Radiol 2001, 56(3):221-224. 10.1053/crad.2000.0620.
38. Love C., Tomas M.B., Marwin S.E., Pugliese P.V., Palestro C.J. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 2001, 21(5):1229-1238.
39. Van der Bruggen W., Bleeker-Rovers C.P., Boerman O.C., Gotthardt M., Oyen W.J. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med 2010, 40(1):3-15. 10.1053/j.semnuclmed.2009.08.005.
40. Graute V., Feist M., Lehner S., Haug A., Müller P.E., Bartenstein P., et al. Detection of low-grade prosthetic joint infections using (99m)Tc-antigranulocyte SPECT/CT: initial clinical results. Eur J Nucl Med Mol Imaging 2010, 37(9):1751-1759.
41. Zeller V., Durand F., Kitzis M.D., Lhotellier L., Ziza J.M., Mamoudy P., et al. Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations. Antimicrob Agents Chemother 2009, 53(3):883-887.
42. Zimmerli W., Widmer A.F., Blatter M., Frei R., Ochsner P.E. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998, 279(19):1537-1541.
43. Berdal J.E., Skråmm I., Mowinckel P., Gulbrandsen P., Bjørnholt J.V. Use of rifampin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect 2005, 11(10):843-845.
44. Stengel D., Bauwens K., Sehouli J., Ekkernkamp A., Porzsolt F. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis 2001, 1(3):175-188.
45. Stein A., Bataille J.F., Drancourt M., Curvale G., Argenson J.N., Groulier P., et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 1998, 42(12):3086-3091.
46. Trampuz A., Zimmerli W. New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Investig Drugs 2005, 6(2):185-190.
47. Bassetti M., Vitale F., Melica G., Righi E., Di Biagio A., Molfetta L., et al. Linezolid in the treatment of gram-positive prosthetic joint infections. J Antimicrob Chemother 2005, 55(3):387-390.
48. Razonable R.R., Osmon D.R., Steckelberg J.M. Linezolid therapy for orthopedic infections. Mayo Clin Proc 2004, 79(9):1137-1144.
49. Nguyen S., Pasquet A., Legout L., Beltrand E., Dubreuil L., Migaud H., et al. Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections. Clin Microbiol Infect 2009, 15(12):1163-1169.
50. Gandelman K., Zhu T., Fahmi O.A., Glue P., Lian K., Obach R.S., et al. Unexpected effect of rifampin on the pharmacokinetics of linezolid: in silico and in vitro approaches to explain its mechanism. J Clin Pharmacol 2010, [Epub ahead of print].
51. Falagas M.E., Giannopoulou K.P., Ntziora F., Papagelopoulos P.J. Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence. Int J Antimicrob Agents 2007 Sep, 30(3):202-209. 10.1016/j.ijantimicag.2007.02.012.
52. Sakoulas G. Clinical outcomes with daptomycin: a post-marketing, real-world evaluation. Clin Microbiol Infect 2009, 15(Suppl. 6):11-16.
53. Yin L.Y., Lazzarini L., Li F., Stevens C.M., Calhoun J.H. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother 2005, 55(6):995-1002.
54. Smith K., Perez A., Ramage G., Gemmell C.G., Lang S. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents 2009, 33(4):374-378. 10.1016/j.ijantimicag.2008.08.029.
55. Bernard L., Legout L., Zurcher-Pfund L., Stern R., Rohner P., Peter R., et al. Six week of antibiotic treatment is sufficient following surgery for septic arthroèlasty. J Infect 2010, 61(2):125-132.
56. Mittal Y., Fehring T.K., Hanssen A., Marculescu C., Odum S.M., Osmon D. Two-stage reimplantation for periprosthetic knee infection involving resistant organisms. J Bone Joint Surg Am 2007, 89(6):1227-1231.
57. Bratzler D.W., Houck P.M. Surgical infection prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention Project. Am J Surg 2005, 189(4):395-404. 10.1016/j.amjsurg.2005.01.015.
58. Berbari E.F., Osmon D.R., Carr A., Hanssen A.D., Baddour L.M., Greene D., et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis 2010, 50(1):8-16. 10.1016/j.jinf.2010.05.005.
59. Information statement: antibiotic prophylaxis for bacteremia in patients with joint replacements American Association of Orthopaedic Surgeons, Available at. http://www.aaos.org/about/papers/advistmt/1033.asp.
60. Bode L.G., Kluytmans J.A., Wertheim H.F., Bogaers D., Vandenbroucke-Grauls C.M., Roosendaal R., et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010, 362(1):9-17.
61. Kalmeijer M.D., Coertjens H., van Nieuwland-Bollen P.M., Bogaers-Hofman D., de Baere G.A., Stuurman A., et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002, 35(4):353-358.
62. Rao N., Cannella B., Crossett L.S., Yates A.J., McGough R. A preoperative decolonization protocol for staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res 2008, 466(6):1343-1348.
63. Kallen A.J., Wilson C.T., Larson R.J. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol 2005, 26(12):916-922.
64. Tacconelli E., De Angelis G., de Waure C., Cataldo M.A., La Torre G., Cauda R. Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis 2009, 9(9):546-554.